Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$10.7M
7M shares
52-week range
$1.25 – $3.11
20% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
XASE
CS
Borrow rate
4.09%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.7M | $20.6M | $17.8M | $17.6M | $19.7M | $21.3M | $28.3M | $28.1M |
| Cost of revenue | $12.2M | $13.7M | $13.4M | $10.9M | $11.4M | $12.0M | $19.2M | $23.0M |
| Gross profit | $7.5M | $6.9M | $4.5M | $6.7M | $8.4M | $9.3M | $9.2M | $5.0M |
| Gross margin | 38.0% | 33.6% | 25.0% | 38.2% | 42.4% | 43.8% | 32.4% | 18.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.9M | −$4.5M | −$9.5M | $1.4M | $2.4M | $270.0K | −$2.8M | −$2.0M |
| EBITDA | $10.3M | $10.3M | −$1.4M | $7.0M | $8.4M | $7.0M | $8.9M | $4.1M |
| Net income | $1.0M | $659.0K | −$7.1M | $194.0K | $1.3M | $610.0K | $2.2M | −$1.6M |
| Net margin | 5.2% | 3.2% | -39.6% | 1.1% | 6.7% | 2.9% | 7.7% | -5.5% |
| EPS (diluted) | 0.17 | 0.24 | -1.14 | 0.03 | 0.21 | 0.10 | 0.33 | -0.23 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $30M | $-0.05 | $-0.05–$-0.05 | 1 |
Forward consensus · source: Financial Modeling Prep
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.
www.ashs.comNo one on the platform currently holds AMS.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 49,200 | $71.3K |
No one on the platform has traded AMS yet.
| $3M |
| — |
| EKSOEkso Bionics Holdings, Inc. | $22.95 | +3.24% | $56M | — |
| ERNAErnexa Therapeutics Inc. | $7.03 | +0.86% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$AMS in algo hands till we get real volume. Ill grab deeper dips and wait for some real action. Have a great weekend all.
View on StockTwits ↗$AMS don’t even say 3 years of holding average sitting at $1.5, so $5—$10 is for u pros to do.
View on StockTwits ↗$AMS a kind suggestion here 5 years holding just for $4 that can be considered a loss only $10 is acceptable for pros.
View on StockTwits ↗$AMS the end of the downtrend always leads to a coming price raise, sadly people don’t read.
View on StockTwits ↗$AMS any signal that the market turns positive will send this to 4ish at least now everybody scared
View on StockTwits ↗$AMS and next wave gonna break 2.4 directly
View on StockTwits ↗$AMS classic second level of uptrend the only problem is the market is not interested in this here
View on StockTwits ↗$AMS depends on which direction they wanna go, depends on the whole market. They been locked enough and manipulates long enough the average been sitting at 1.5ish already I do believe MM and insiders has a price range from 1.5—2
View on StockTwits ↗$AMS Wow. that dude this morning might have been correct with the $1.43 close.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 7.2× earnings vs its 20.1× historical median P/E.
Fair value ≈ $4.52 · price $1.63 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.